{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:48:50Z","timestamp":1773182930113,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["WEF 01\/09\/2019"],"award-info":[{"award-number":["WEF 01\/09\/2019"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.crad.2020.12.022","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T04:23:18Z","timestamp":1612930998000},"page":"391.e1-391.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift"],"prefix":"10.1016","volume":"76","author":[{"given":"S.","family":"Zafar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.","family":"Attygalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"El-Sharkawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.crad.2020.12.022_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.crad.2020.12.022_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrclinonc.2017.78","article-title":"Evolution of lymphoma staging and response evaluation: current limitations and future directions","volume":"14","author":"Cunningham","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.crad.2020.12.022_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1148\/rg.2020190198","article-title":"Breast implant-associated anaplastic large cell lymphoma: review and multiparametric imaging paradigms","volume":"40","author":"Sharma","year":"2020","journal-title":"RadioGraphics"},{"issue":"11","key":"10.1016\/j.crad.2020.12.022_bib5","first-page":"1860","article-title":"Report of the committee on Hodgkin\u2019s disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"issue":"27","key":"10.1016\/j.crad.2020.12.022_bib6","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.crad.2020.12.022_bib7","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1111\/bjh.16580","article-title":"Focal splenic lesions in indolent B-NHL: association with high grade transformation and safe percutaneous biopsy","volume":"189","author":"Mir","year":"2020","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1016\/j.crad.2020.12.022_bib8","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2016-05-718528","article-title":"Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy","volume":"128","author":"Cheson","year":"2016","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.crad.2020.12.022_bib9","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1200\/JCO.2005.01.904","article-title":"Role of positron emission tomography in lymphoma","volume":"23","author":"Juweid","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.crad.2020.12.022_bib10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s13244-010-0062-3","article-title":"Causes and imaging features of false positives and false negatives on F-PET\/CT in oncologic imaging","volume":"2","author":"Long","year":"2011","journal-title":"Insights Imaging"},{"issue":"12","key":"10.1016\/j.crad.2020.12.022_bib11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrclinonc.2012.195","article-title":"Imaging in oncology\u2014over a century of advances","volume":"9","author":"Sharma","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.crad.2020.12.022_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2214\/ajr.143.1.37","article-title":"Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin disease","volume":"143","author":"Castellino","year":"1984","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.crad.2020.12.022_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.crad.2020.12.022_bib14","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international Workshop to standardize response criteria for non-hodgkin\u2019s lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.crad.2020.12.022_bib15","first-page":"1023","article-title":"Validity of the Ann Arbor staging classification for the non-Hodgkin\u2019s lymphomas","volume":"61","author":"Rosenberg","year":"1977","journal-title":"Cancer Treat Rep"},{"issue":"1","key":"10.1016\/j.crad.2020.12.022_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/00313027909063538","article-title":"Bilateral trephine bone marrow biopsies in Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma","volume":"11","author":"Menon","year":"1979","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.crad.2020.12.022_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-82-3-365","article-title":"Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases","volume":"82","author":"Brunning","year":"1975","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.crad.2020.12.022_bib18","doi-asserted-by":"crossref","first-page":"20110086","DOI":"10.1259\/imaging.20110086","article-title":"Positron emission tomography\/CT in the management of lymphoma","volume":"22","author":"Martin","year":"2013","journal-title":"Imaging"},{"issue":"7","key":"10.1016\/j.crad.2020.12.022_bib19","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","article-title":"International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)","volume":"28","author":"Younes","year":"2017","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"15","key":"10.1016\/j.crad.2020.12.022_bib20","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.crad.2020.12.022_bib21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3324\/haematol.2018.192492","article-title":"End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making","volume":"103","author":"Melani","year":"2018","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.crad.2020.12.022_bib22","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1111\/bjh.16679","article-title":"LyRIC indeterminate response and Immune-mediated pseudoprogression of diffuse large B-cell lymphoma following polatuzumab-based salvage therapy","volume":"189","author":"Lee","year":"2020","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.crad.2020.12.022_bib24","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3109\/10428194.2012.677535","article-title":"Report on the third international Workshop on interim positron emission tomography in lymphoma held in Menton, France, 26\u201327 September 2011 and Menton 2011 consensus","volume":"53","author":"Meignan","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.crad.2020.12.022_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/10428194.2013.802784","article-title":"Report on the 4th international Workshop on positron emission tomography in lymphoma held in Menton, France, 3\u20135 October 2012","volume":"55","author":"Meignan","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.crad.2020.12.022_bib26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3109\/10428194.2015.1029748","article-title":"Report on the 5th international Workshop on positron emission tomography in lymphoma held in Menton, France, 19-20 September 2014","volume":"56","author":"Meignan","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.crad.2020.12.022_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.acra.2015.09.009","article-title":"RadPath: a web-based system for integrating and correlating radiology and pathology findings during cancer diagnosis","volume":"23","author":"Arnold","year":"2016","journal-title":"Acad Radiol"},{"key":"10.1016\/j.crad.2020.12.022_bib28","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2019-126155","article-title":"Implementing a specialist integrated haematological malignancy imaging reporting paradigm to lymphoma radiology assessment can significantly improve the quality of data for patient management and clinical research","volume":"134","author":"Mahalingam","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.crad.2020.12.022_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13550-020-00698-y","article-title":"Baseline total metabolic tumour volume combined with international peripheral T-cell lymphoma project may improve prognostic stratification for patients with peripheral T-cell lymphoma (PTCL)","volume":"10","author":"Jiang","year":"2020","journal-title":"EJNMMI Res"},{"issue":"30","key":"10.1016\/j.crad.2020.12.022_bib30","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2016.69.3747","article-title":"Metabolic tumour volume in lymphoma: hype or hope?","volume":"34","author":"Sch\u00f6der","year":"2016","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.crad.2020.12.022_bib31","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2011.36.9348","article-title":"Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial","volume":"30","author":"B\u00f6ttcher","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2020.12.022_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-62703-269-8_10","article-title":"MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR","volume":"971","author":"Pott","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.crad.2020.12.022_bib33","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/leu.2013.375","article-title":"Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders","volume":"28","author":"Ladetto","year":"2014","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.crad.2020.12.022_bib34","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00330-008-0857-5","article-title":"PET\/MRI hybrid imaging: devices and initial results","volume":"18","author":"Pichler","year":"2008","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.crad.2020.12.022_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1593\/neo.81328","article-title":"Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations","volume":"11","author":"Padhani","year":"2009","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.crad.2020.12.022_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiology.161.2.3763909","article-title":"MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders","volume":"161","author":"Le Bihan","year":"1986","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.crad.2020.12.022_bib37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.21037\/atm.2018.08.05","article-title":"Machine learning for semi-automated classification of glioblastoma, brain metastasis and central nervous system lymphoma using magnetic resonance advanced imaging","volume":"7","author":"Swinburne","year":"2019","journal-title":"Ann Transl Med"},{"issue":"2","key":"10.1016\/j.crad.2020.12.022_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.mri.2011.09.019","article-title":"The clinical application of whole-body diffusion-weighted imaging in the early assessment of chemotherapeutic effects in lymphoma: the initial experience","volume":"30","author":"Chen","year":"2012","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"10.1016\/j.crad.2020.12.022_bib39","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/leu.2015.338","article-title":"Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?","volume":"30","author":"Pawlyn","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.crad.2020.12.022_bib40","doi-asserted-by":"crossref","first-page":"20120013","DOI":"10.1259\/imaging.20120013","article-title":"Picture quiz: recurrent FDG-uptake in the anterior mediastinum of a young man previously treated for Hodgkin lymphoma","volume":"22","author":"Sharma","year":"2013","journal-title":"Imaging"},{"issue":"4","key":"10.1016\/j.crad.2020.12.022_bib41","first-page":"249","article-title":"Quantitative diffusion weighted MRI: a functional biomarker of nodal disease in Hodgkin lymphoma?","volume":"7","author":"Punwani","year":"2010","journal-title":"Cancer Biomark"},{"issue":"11","key":"10.1016\/j.crad.2020.12.022_bib42","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-14-2454","article-title":"Evaluation of diffusion-weighted magnetic resonance imaging for follow-up and treatment response assessment of lymphoma: results of an 18F-FDG-PET\/CT\u2014controlled prospective study in 64 patients","volume":"21","author":"Mayerhoefer","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.crad.2020.12.022_bib43","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1158\/1078-0432.CCR-13-3355","article-title":"Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients","volume":"20","author":"Mayerhoefer","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.crad.2020.12.022_bib44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/nbm.1261","article-title":"Monitoring response to chemotherapy of non-Hodgkin\u2019s lymphoma xenografts by T(2)-weighted and diffusion-weighted MRI","volume":"21","author":"Huang","year":"2008","journal-title":"NMR Biomed"},{"issue":"2","key":"10.1016\/j.crad.2020.12.022_bib45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0284185114526087","article-title":"Diffusion-weighted MRI compared to FDG PET\/CT for assessment of early treatment response in lymphoma","volume":"56","author":"Hagtvedt","year":"2015","journal-title":"Acta Radiol"},{"issue":"11","key":"10.1016\/j.crad.2020.12.022_bib46","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/3337","article-title":"Imaging proliferation in\u00a0vivo with [F-18]FLT and positron emission tomography","volume":"4","author":"Shields","year":"1998","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.crad.2020.12.022_bib47","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nbt1306","article-title":"Decoding global gene expression programs in liver cancer by noninvasive imaging","volume":"25","author":"Segal","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.crad.2020.12.022_bib48","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tranon.2014.07.007","article-title":"NCI Workshop Report: clinical and computational requirements for correlating imaging phenotypes with genomics signatures","volume":"7","author":"Colen","year":"2014","journal-title":"Transl Oncol"},{"issue":"2","key":"10.1016\/j.crad.2020.12.022_bib49","first-page":"153","article-title":"Automated diagnosis of lymphoma with digital pathology images using deep learning","volume":"49","author":"Achi","year":"2019","journal-title":"Ann Clin Lab Sci"},{"issue":"4","key":"10.1016\/j.crad.2020.12.022_bib50","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s11307-020-01474-z","article-title":"Optimizing workflows for fast and reliable metabolic tumour volume measurements in diffuse large B cell lymphoma","volume":"22","author":"Burggraaff","year":"2020","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"10.1016\/j.crad.2020.12.022_bib51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.120.242412","article-title":"Deep learning FDG uptake classification enables total metabolic tumour volume estimation in diffuse large B-cell lymphoma","volume":"62","author":"Capobianco","year":"2021","journal-title":"J Nucl Med"},{"issue":"26","key":"10.1016\/j.crad.2020.12.022_bib52","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2015.65.6520","article-title":"CNS International Prognostic Index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"34","author":"Schmitz","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.crad.2020.12.022_bib53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1349-7006.2011.02139.x","article-title":"Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era","volume":"103","author":"Tomita","year":"2012","journal-title":"Cancer Sci"},{"issue":"10","key":"10.1016\/j.crad.2020.12.022_bib54","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.3109\/10428194.2013.869326","article-title":"Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era","volume":"55","author":"Fletcher","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.crad.2020.12.022_bib55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bjh.12509","article-title":"Guideline on the prevention of secondary central nervous system lymphoma: British Committee for Standards in Haematology","volume":"163","author":"McMillan","year":"2013","journal-title":"Br J Haematol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:36:50Z","timestamp":1773113810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926021000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0009926021000179"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2020.12.022","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2020.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}